Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Duffaud F"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Gantzer J; Department of Medical Oncology, Institut de Cancérologie de Strasbourg-Europe, Strasbourg, France., Toulmonde M; Department of Medical Oncology, Institut Bergonié, Bordeaux, France., Severac F; Department of Public Health, Hôpitaux Universitaires de Strasbourg, Strasbourg, France., Chamseddine AN; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France., Charon-Barra C; Department of Pathology, Centre Georges François Leclerc, Dijon, France., Vinson C; Department of Pathology, Centre Georges François Leclerc, Dijon, France., Hervieu A; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France., Bourgmayer A; Department of Medical Oncology, Institut de Cancérologie de Strasbourg-Europe, Strasbourg, France., Bertucci F; Department of Medical Oncology, Institut Paoli-Calmettes, Marseilles, France., Ryckewaert T; Department of Medical Oncology, Centre Oscar Lambret, Lille, France., Valentin T; Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Firmin N; Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France., Chaigneau L; Department of Medical Oncology, Institut Regional du Cancer en Franche-Comté, Besançon, France., Bompas E; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France., Follana P; Department of Medical Oncology, Centre Antoine-Lacassagne, Nice, France., Rioux-Leclercq N; Department of Pathology, Centre Hospitalier Universitaire de Rennes, Rennes, France., Soibinet-Oudot P; Department of Medical Oncology, Institut Godinot, Reims, France., Bozec L; Department of Medical Oncology, Institut Curie, Saint-Cloud, France., Le Loarer F; Department of Pathology, Institut Bergonié, Bordeaux, France., Weingertner N; Department of Pathology, Hôpitaux Universitaires de Strasbourg, Strasbourg, France., Chevreau C; Department of Medical Oncology, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Duffaud F; Department of Medical Oncology, Centre Hospitalier Universitaire de Marseilles, Marseilles, France., Blay JY; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Kurtz JE; Department of Medical Oncology, Institut de Cancérologie de Strasbourg-Europe, Strasbourg, France., Schöffski P; Department of Medical Oncology, University Hospitals, Leuven, Belgium., Brahmi M; Department of Medical Oncology, Centre Léon Bérard, Lyon, France., Malouf GG; Department of Medical Oncology, Institut de Cancérologie de Strasbourg-Europe, Strasbourg, France.
Publikováno v:
Cancer [Cancer] 2024 Jul 01; Vol. 130 (13), pp. 2304-2314. Date of Electronic Publication: 2024 Mar 12.
Autor:
Chen TW; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan., Chiang RC; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.; Taiwan Cancer Registry, Taipei, Taiwan., Le Cesne A; Medical Oncology, Gustave Roussy Institute-Cancer Campus, Villejuif, France., Hsieh YC; Health Data Research Center, National Taiwan University, Taipei, Taiwan., Italiano A; Early Phase Trials Unit, Bergonie Institute, Bordeaux, France., Yang YW; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.; Taiwan Cancer Registry, Taipei, Taiwan., Penel N; General Oncology Department, Oscar Lambret Center, Lille, France., Lee WC; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.; Taiwan Cancer Registry, Taipei, Taiwan., Bompas E; Western Oncology Institute, Nantes, France., Valentin T; Claudius Regaud Institute, Toulouse, France., Anract P; Department of Orthopedics, Assistance publique Hopitaux de Paris, Paris, France., Firmin N; Montpellier Cancer Institute, Montpellier, France., Duffaud F; Medical Oncology, Greater Paris University Hospitals, Marseilles, France., Cheng AL; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan., Ducimetiere F; Medicine Department, Leon Berard Center, Lyon, France., Chan KA; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan., Blay JY; Medicine Department, Leon Berard Center, Lyon, France.
Publikováno v:
Cancer [Cancer] 2022 Sep 15; Vol. 128 (18), pp. 3360-3369. Date of Electronic Publication: 2022 Jul 07.
Autor:
D'Ambrosio L; Department of Oncology, University of Turin, Turin, Italy.; Sarcoma Unit, Division of Medical Oncology, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy., Touati N; European Organization for Research and Treatment of Cancer, Brussels, Belgium., Blay JY; Leon Berard Center and Claude Bernard Lyon I University, EURACAN, LYRICAN, Lyon, France., Grignani G; Sarcoma Unit, Division of Medical Oncology, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy., Flippot R; Department of Medicine, Gustave Roussy, Villejuif Cedex, France., Czarnecka AM; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute-Oncology Center, Gliwice, Poland.; Department of Experimental Pharmacology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland., Piperno-Neumann S; Medical Oncology Department, Curie Institute, Paris, France., Martin-Broto J; Virgen del Rocio University Hospital, Institute of Biomedicine Research/CSIC/University of Seville, Seville, Spain., Sanfilippo R; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Katz D; Oncology Department, Sharett Institute of Oncology, Hadassah-Hebrew University, Jerusalem, Israel., Duffaud F; Medical Oncology - University Hospital Timone, Aix-Marseille University, Marseille, France., Vincenzi B; Department of Medical Oncology, Campus Bio-Medico University of Rome, Rome, Italy., Stark DP; St James's Institute of Oncology, Leeds Institute of Cancer and Pathology, University of Leeds and Leeds Teaching Hospitals National Health Service Trust, Leeds, United Kingdom., Mazzeo F; Medical Oncology, Clinique Universitaire Saint-Luc, Woluwe-Saint-Lambert, Belgium., Tuchscherer A; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany., Chevreau C; Claudius Regaud Institute, University Cancer Institute of Toulouse, Toulouse, France., Sherriff J; Cancer Centre, Queen Elizabeth Hospital, Birmingham, United Kingdom., Estival A; Catalan Institute of Oncology, Barcelona, Spain., Litière S; European Organization for Research and Treatment of Cancer, Brussels, Belgium., Sents W; European Organization for Research and Treatment of Cancer, Brussels, Belgium., Ray-Coquard I; Leon Berard Center and Claude Bernard Lyon I University, EURACAN, LYRICAN, Lyon, France., Tolomeo F; Sarcoma Unit, Division of Medical Oncology, Candiolo Cancer Institute-FPO, IRCCS, Candiolo, Italy., Le Cesne A; Department of Medicine, Gustave Roussy, Villejuif Cedex, France., Rutkowski P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute-Oncology Center, Gliwice, Poland.; Department of Experimental Pharmacology, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland., Stacchiotti S; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Kasper B; Sarcoma Unit, Interdisciplinary Tumor Center, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands., Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Publikováno v:
Cancer [Cancer] 2020 Jun 01; Vol. 126 (11), pp. 2637-2647. Date of Electronic Publication: 2020 Mar 04.
Autor:
Frezza AM; Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale Tumori, Milan, Italy., Assi T; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France., Lo Vullo S; Unit of Clinical Epidemiology and Trial Organization, IRCCS Fondazione Istituto Nazionale Tumori, Milan, Italy., Ben-Ami E; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Dufresne A; Department of Medical Oncology, Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France., Yonemori K; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan., Noguchi E; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan., Siontis B; Department of Medicine, University of Michigan, Ann Arbor, Michigan., Ferraro R; Department of Medicine, Sarcoma Medical Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Teterycz P; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland., Duffaud F; Department of Medical Oncology, La Timone University Hospital, Aix-Marseille Université, Marseille, France., Ravi V; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Vincenzi B; Department of Medical Oncology, Università Campus Bio-Medico di Roma, Rome, Italy., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands., Pantaleo MA; Department of Specialized, Experimental and Diagnostic Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Bologna, Italy., Baldi GG; Department of Medical Oncology, Nuovo Ospedale 'S. Stefano,', Prato, Italy., Desar I; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands., Fedenko A; Department of Medical Oncology, N. N. Blokhin Russian Cancer Research, Moscow, Russian Federation., Maki RG; Medical Oncology, Northwell Cancer Institute and Cold Spring Harbor Laboratory, Long Island, New York., Jones RL; Sarcoma Unit, Royal Marsden NHS Foundation Trust/Institute of Cancer Research, London, United Kingdom., Benjamin RS; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Blay JY; Department of Medical Oncology, Centre Léon Bérard & Université Claude Bernard Lyon I, Lyon, France., Kawai A; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan., Gounder M; Department of Medicine, Sarcoma Medical Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Gronchi A; Sarcoma Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Le Cesne A; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France., Mir O; Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France., Czarnecka AM; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Institute-Oncology Center, Warsaw, Poland., Schuetze S; Department of Medicine, University of Michigan, Ann Arbor, Michigan., Wagner AJ; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Adam J; Department of Pathology, Gustave Roussy Cancer Campus, Villejuif, France., Barisella M; Department of Diagnostic Pathology and Laboratory Medicine, IRCCS Fondazione Istituto Nazionale dei Tumori, Milan, Italy., Sbaraglia M; Department of Pathology, Treviso Regional Hospital, Italy., Hornick JL; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts., Meurgey A; Department of Biopathology, Centre Léon Bérard, Lyon, France., Mariani L; Unit of Clinical Epidemiology and Trial Organization, IRCCS Fondazione Istituto Nazionale Tumori, Milan, Italy., Casali PG; Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale Tumori, Milan, Italy.; Department of Oncology and Hemato-oncology, University of Milan, Milan, Italy., Thornton K; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Stacchiotti S; Department of Medical Oncology, IRCCS Fondazione Istituto Nazionale Tumori, Milan, Italy.
Publikováno v:
Cancer [Cancer] 2020 Jan 01; Vol. 126 (1), pp. 98-104. Date of Electronic Publication: 2019 Sep 19.
Autor:
Salas S; Service d'Oncologie Médicale Adulte, CHU Timone, APHM, 264 rue Saint Pierre, Marseille, France. sebastien.salas@ap-hm.fr, Huynh TK, Giorgi R, Deville JL, Bollini G, Curvale G, Blesius A, Gentet JC, Bui B, Bouvier C, Duffaud F
Publikováno v:
European journal of cancer care [Eur J Cancer Care (Engl)] 2011 May; Vol. 20 (3), pp. 322-9.
Autor:
Duffaud F; Department of Medical Oncology, C.H.U. 'La Timone,' Marseille, France., Digue L, Baciuchka-Palmaro M, Volot F, Perles-Daniel C, Garbe L, Favre R
Publikováno v:
Cancer [Cancer] 2000 Jan 15; Vol. 88 (2), pp. 324-32.